We serve Chemical Name:5-Aminopyrimidine-2-carboxylic acid CAS:56621-98-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Aminopyrimidine-2-carboxylic acid
CAS.NO:56621-98-8
Synonyms:5-aminopyrimidine-2-carboxylic acid
Molecular Formula:C5H5N3O2
Molecular Weight:139.11200
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:484.8ºC at 760 mmHg
Density:1.533 g/cm3
Index of Refraction:1.663
PSA:89.10000
Exact Mass:139.03800
LogP:0.33820
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-aminopyrimidine-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-aminopyrimidine-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-aminopyrimidine-2-carboxylic acid Use and application,5-aminopyrimidine-2-carboxylic acid technical grade,usp/ep/jp grade.
Related News: As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. 5-Aminopyrimidine-2-carboxylic acid manufacturer After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API. 5-Aminopyrimidine-2-carboxylic acid supplier The death toll in China rose to at least 304. 5-Aminopyrimidine-2-carboxylic acid vendor The death toll in China rose to at least 304. 5-Aminopyrimidine-2-carboxylic acid factory China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price.
